AbbVie Balance Sheet
ABBV / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
AbbVie had $134.0B in total assets with negative shareholders' equity of $3.3B as of FY2025. Total debt was $64.5B against $5.2B in cash, resulting in $59.3B net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.2B | $5.5B | $12.8B | $9.2B | $9.7B | $8.4B | $39.9B | $7.3B | $9.3B | $5.1B | $8.4B | $8.3B | $9.6B | $5.9B | $27.0M |
| Accounts Receivable | $12.6B | $10.9B | $11.2B | $11.3B | $10.0B | $8.8B | $5.4B | $5.4B | $5.1B | - | - | - | - | - | - |
| Inventory | $5.0B | $4.2B | $4.1B | $3.6B | $3.1B | $3.3B | $1.8B | $1.6B | $1.6B | $1.4B | $1.7B | $1.1B | $1.1B | $1.1B | - |
| Current Assets | $29.1B | $25.6B | $33.0B | $28.5B | $27.9B | $24.2B | $49.5B | $16.9B | $21.2B | $16.2B | $16.3B | $16.1B | $17.8B | $15.4B | - |
| PP&E (Net) | $5.6B | $5.1B | $5.0B | $4.9B | $5.1B | $5.2B | $3.0B | $2.9B | $2.8B | $2.6B | $2.6B | $2.5B | $2.3B | $2.2B | - |
| Goodwill | $35.6B | $35.0B | $32.3B | $32.2B | $32.4B | $33.1B | $15.6B | $15.7B | $15.8B | $15.4B | $13.2B | $5.9B | $6.3B | $6.1B | $6.1B |
| Total Assets | $134.0B | $135.2B | $134.7B | $138.8B | $146.5B | $150.6B | $89.1B | $59.4B | $70.8B | $66.1B | $53.0B | $27.5B | $29.2B | $27.0B | - |
| Current Liabilities | $43.3B | $38.7B | $37.8B | $29.5B | $35.2B | $28.7B | $15.6B | $17.2B | $16.6B | $9.8B | $10.9B | $11.4B | $6.9B | $6.8B | - |
| Total Debt | $64.5B | $66.8B | $59.2B | $63.1B | $76.0B | $84.9B | $67.2B | - | - | - | - | - | - | - | - |
| Shareholders' Equity | -$3.3B | $3.3B | $10.4B | $17.3B | $15.4B | $13.1B | -$8.2B | -$8.4B | $5.1B | $4.6B | $3.9B | $1.7B | $4.5B | -$350.0M | - |